JULIANNE WONG: Open Payments
NPI 1881949626 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 32 payments from 16 companies in 2025. Trend: 2023 $22 · 2024 $1,036 · 2025 $1,081
Food & beverage: $1,081
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $289 |
| AstraZeneca Pharmaceuticals LP | 5 | $200 |
| Madrigal Pharmaceuticals | 1 | $135 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Exact Sciences Corporation | 2 | $57 |
| Hologic Sales and Service, LLC | 2 | $50 |
| ABBVIE INC. | 2 | $42 |
| Dexcom, Inc. | 1 | $31 |
| Gilead Sciences, Inc. | 1 | $25 |
Products named: ZEPBOUND, REZDIFFRA, BREZTRI, Cologuard Collection Kit, MOUNJARO, SHINGRIX, QULIPTA, Kerendia.
Industry payments across CO — which companies pay providers there.
